Expedia spooks investors with CEO change
By Claudia Assis
Expedia stock drops 13% despite quarterly beat
Expedia Group Inc. shares fell 13% in the extended session Thursday, as investors appeared nervous by a CEO change and looked past a quarterly beat for the online travel company.
Expedia (EXPE) earned $132 million, or 92 cents a share, in the fourth quarter, compared with $177 million, or $1.11 a share, in the year-ago period.
Adjusted for one-time items, the company earned $1.72 a share. Revenue rose 10% to $2.89 billion. Analysts polled by FactSet expected adjusted EPS of $1.67 on revenue of $2.87 billion.
"We delivered on our full-year guidance and drove record results, all while completing a massive transformation and navigating the inherent volatility that comes with that," Chief Executive Peter Kern said in a statement. "Our work is finally starting to deliver results, and we are in the best place we've ever been technologically."
In a separate press release, however, Expedia said that Kern was being replaced by Ariane Gorin, who has held various executive roles at Expedia since 2013 and most recently served as president of Expedia for Business.
The appointment is effective on May 13, the company said. Kern has served as Expedia CEO since 2020 and will remain a board member and the company's vice chairman to "ensure a smooth transition," Expedia said.
Shares of Expedia ended the regular trading day Thursday up 3.3%. The stock has gained 33% in the past 12 months, compared with an advance of 21% for the S&P 500 index SPX in the same period.
-Claudia Assis
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
02-08-24 2103ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track